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Background: It was reported that there is an inverse relation-
ship between thepresence ofH.pylori and asthmaandTh2 response
may be directed to the Th1 response in asthmatic persons by HP-
NAP A. We reporte the H.pylori quantity in the gut microbiota of
children with allergic asthma comparing with that of healthy con-
trols. Additionnaly we report the gene expression levels of HP-NAP
A.
Methods&Materials: FromMarch 2014 to January 2015 bacte-
rial DNA and RNAwere isolated from stool samples of 92 asthmatic
children aged from 3 to 8 years and from stool samples of 88 age,
and gender matched healthy controls. The quantity of H.pylori was
determined by Real Time PCR and cDNA synthesis was made from
the isolatedRNA. The gene expression studieswere conductedwith
HP-NAP A gene(Accession No: U16121.1) and with 16S rRNA gene,
primers, probes, cDNAs and Lightcycler 480 Probe master kit, RD
in LightCycler 96 instrument. The Cq values obtained from HP-
NAP A gene were compared with that of 16S rRNA reference gene
and gene expression analyses were performed using delta delta-
Ct(ddCt) method.
Results: H.pylori DNAwas found negative in stool samples of all
92 asthmatic children and positive in 18(% 20,4) of 88 healthy con-
trols. A statistically signiﬁcant difference was found between these
groups(p< 0,0001, OR =0,79). The quantity of H.pylori determined
by qPCR was higher in 7 of 18 H.pylori positive samples but despite
that, in 4 of these 7 samples, the detected HP-NAP A expression
levels was low comparing with the levels obtained from 8(8/11) of
the remaining 11 H.pylori positive samples.
Conclusion: Our ﬁndings supports the opinion about the pres-
ence of an inverse relationship between H.pylori infection and
asthma. Additionnaly, we belive that as well as the presence of
HP-NAP A, its expression level plays an important role in the
immunomodulation and we can think that its protective effect
against asthma is related with the expression level of HP-NAP A
rather then the quantity of H.pylori in the fecal microbiota. We
belive that more extensive researches with different approaches
and different perspectives are needed.
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A case of Actinomyces meyeri empyema: still a
challenging entity management
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Background: Actinomycosis is an uncommon chronic infection
caused by a group of anaerobic Gram-positive bacilli belong-
ing to the Actinomyces genus, being Actinomyces israelii the most
frequently implicated in human diseases. Actinomyces meyeri, in
dissimilarity to other species of Actinomyces, is an unusual cause
of human actinomycosis, regularly causes pulmonary disease and
shows a propensity for hematogenous dissemination. Infection of
the respiratory system due to A. meyeri presents with nonspeciﬁc
symptoms and has no distinctive ﬁndings of diagnostic value in
radiological tests. Consequently, microbiological and histological
and examinations are imperative for diagnosis.
Methods & Materials: Here, we report a rare case of empyema
caused by A. meyeri.
Results: A 44-year-old male presented with a history of 4
months of dyspnea and chest pain. A large amount of loculated
pleural effusionwas present on the right side andwas documented
on radiological studies (Figure 1). A chest tube was inserted and
purulent pleural ﬂuid was drained. A. meyeri was isolated in anaer-
obic cultures of the pleural ﬂuid. The infection was signiﬁcantly
improved in response to treatment with intravenous clindamycin
(4800mg daily) and oral clindamicin (450mg every 6 hours) for a
period of 4 months (Figure 2).
Large loculated effusion in the right hemithorax
